Fredric Eshelman

This profile gathers the share dealings of Fredric Eshelman in Valeant Pharmaceuticals International, Inc. Over a trading history stretching from 8 March 2016 to 3 May 2017, the count stands at 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 8 May 2017, the filings show an option exercise worth €108k in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEDI, the median delay is 41 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.